DCD approval processes hold a vital role in driving innovation within the healthcare landscape. By implementing streamlined strategies, regulatory bodies can expedite the production of new medications that have the potential to transform patient care. Moreover, a more streamlined approval process can incentivize investment in innovation, leading to